Atlas Trials

Lambert-eaton Myasthenic Syndrome

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lambert-eaton Myasthenic Syndrome

RecordFirmDate
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes (NCT05408702)Institut de Myologie, France2021-11-12
Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) (NCT02970162)Catalyst Pharmaceuticals, Inc.2016-11-01
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (NCT01511978)Jacobus Pharmaceutical2012-01-01
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (NCT00716066)Fred Hutchinson Cancer Center2008-06-01
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome (NCT01373333)The Cleveland Clinic1997-09-01
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (NCT00004832)FDA Office of Orphan Products Development1994-08-01
Treatment of Lambert-Eaton Syndrome With 3,4 DAP (NCT00704925)David P. Richman, MD
3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) (NCT00872950)Lahey Clinic
Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome (NCT01825395)University of Colorado, Denver
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine (NCT00994916)David Lacomis, MD
Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome (NCT02189720)Catalyst Pharmaceuticals, Inc.

Track Lambert-eaton Myasthenic Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.